From an international and US perspective, why do you find the Medicon Valley cluster interesting?
The Medicon Valley cluster is fascinating as a successful model of cross-border collaboration, demonstrating how shared goals and geographical proximity can create a powerful innovation hub for others to learn from, including within the US. Its high concentration of research institutions and talent fuels fundamental discoveries and provides a rich pipeline for commercialization. The strong public-private partnerships and supportive ecosystems established by the Danish and Swedish governments create a productive environment for innovation and attract global investment, offering valuable lessons for the US in further strengthening its own innovation environment. The cluster’s ecosystem, where startups thrive alongside established companies, fosters breakthroughs that have global impact. Ultimately, Medicon Valley serves as a compelling example of how a focused, collaborative, and well-supported life science ecosystem in Denmark and Sweden generates innovations that contribute to global health and the advancement of medicine, benefiting patients internationally, including those in the US.
What are in your view the key elements of any successful strategy for medtech companies looking to bring their technology to the US?
A2: In my view, a successful strategy for Medtech companies looking to bring their technology to the US hinges on several key elements. Firstly, a fundamental understanding of the economic value your product creates for all stakeholders within the complex US healthcare system is paramount. This goes beyond simply demonstrating clinical efficacy. You need to articulate how your technology will drive cost savings, improve patient outcomes in a measurable way, enhance efficiency for providers, and offer benefits to payers. Without a clear and compelling value proposition tailored to each stakeholder, gaining traction and reimbursement will be a significant hurdle.
Secondly, strategically deciding where to establish your company presence in the US is a crucial step with numerous considerations to think through. This decision impacts access to talent, proximity to key opinion leaders and research institutions, potential for partnerships, state-specific regulations and tax environments, and ultimately, your ability to effectively navigate the US market. A well-thought-out location strategy can provide a significant competitive advantage.
How do you believe Project Medtech can create value for the medtech eco-system in the Nordics?
As Project Medtech, a leading consultancy dedicated to accelerating medical technology, I believe we can create significant value for the Nordic Medtech ecosystem through our comprehensive expertise and collaborative vision. By leveraging our insights from the US market and global best practices, we can bridge the gap between Nordic innovation and international success, offering invaluable guidance on US market access, reimbursement, and investor expectations while also highlighting unique Nordic strengths. Our expertise in strategic finance and investment strategy can attract crucial international funding to Nordic companies, while our corporate strategy guidance can facilitate strategic partnerships and M&A activities that strengthen the entire ecosystem. Furthermore, our capabilities in regulatory affairs and quality assurance are vital for Nordic companies seeking global expansion, particularly into the US, ensuring compliance and product safety. Through our events and insightful content, we can connect Nordic players with a broader international network, disseminate critical knowledge on market access and health economics, and foster a more interconnected and collaborative Nordic Medtech community. Ultimately, our diverse skills and global perspective can address specific Nordic needs, such as tailored go-to-market strategies in a global market, acting as a catalyst for innovation and enabling Nordic Medtech companies to achieve greater global success and ultimately improve patient lives worldwide.
Learn more about Project Medtech